Partial restoration of cardiac function with ΔPDZ nNOS in aged mdx model of Duchenne cardiomyopathy

Human Molecular Genetics

Volumn 23, Issue 12, 2014, Pages 3189-3199

  Lai, Yi ^a   Zhao, Junling ^a   Yue, Yongping ^a   Wasala, Nalinda B ^a   Duan, Dongsheng ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; PARVOVIRUS VECTOR; PDZ DOMAIN DELETED NEURONAL NITRIC OXIDE SYNTHASE; PHOSPHOLAMBAN; S6 KINASE; TYROSINE; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; NOS1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EFFICACY; DUCHENNE CARDIOMYOPATHY; DUCHENNE MUSCULAR DYSTROPHY; ELECTROCARDIOGRAPHY; ENZYME PHOSPHORYLATION; FEMALE; GENE DELETION; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART PROTECTION; MOUSE; MYOCARDITIS; NONHUMAN; PDZ DOMAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TREATMENT OUTCOME; VIRAL GENE THERAPY; ANIMAL; C57BL MOUSE; CARDIOMYOPATHIES; COMPLICATION; DEPENDOPARVOVIRUS; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; METABOLISM; MUSCULAR DYSTROPHY, ANIMAL; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROCEDURES; SIGNAL TRANSDUCTION; THERAPEUTIC USE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; APOPTOSIS; CALCIUM-BINDING PROTEINS; CARDIOMYOPATHIES; DEPENDOVIRUS; FEMALE; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCULAR DYSTROPHY, ANIMAL; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE I; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION;

EID: 84901323875     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu029     Document Type: Article

References (53)

1. Zhang, Y.H. and Casadei, B. (2012) Sub-cellular targeting of constitutive NOS in health and disease. J. Mol. Cell Cardiol., 52, 341-350.
2. Sears, C.E., Bryant, S.M., Ashley, E.A., Lygate, C.A., Rakovic, S., Wallis, H.L., Neubauer, S., Terrar, D.A. and Casadei, B. (2003) Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ. Res., 92, e52-e59.
3. Khan, S.A., Skaf, M.W., Harrison, R.W., Lee, K., Minhas, K.M., Kumar, A., Fradley, M., Shoukas, A.A., Berkowitz, D.E. and Hare, J.M. (2003) Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ. Res., 92, 1322-1329.
4. Ashley, E.A., Sears, C.E., Bryant, S.M., Watkins, H.C. and Casadei, B. (2002) Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes. Circulation, 105, 3011-3016.
5. Steppan, J., Ryoo, S., Schuleri, K.H., Gregg, C., Hasan, R.K., White, A.R., Bugaj, L.J., Khan, M., Santhanam, L., Nyhan, D. et al. (2006) Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. Proc. Natl. Acad. Sci. USA, 103, 4759-4764.
6. Khan, S.A., Lee, K., Minhas, K.M., Gonzalez, D.R., Raju, S.V., Tejani, A.D., Li, D., Berkowitz, D.E. and Hare, J.M. (2004) Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc. Natl. Acad. Sci. USA, 101, 15944- 15948.
7. Kinugawa, S., Huang, H., Wang, Z., Kaminski, P.M., Wolin, M.S. and Hintze, T.H. (2005) A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase. Circ. Res., 96, 355-362.
8. Dawson, D., Lygate, C.A., Zhang, M.H., Hulbert, K., Neubauer, S. and Casadei, B. (2005) nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation, 112, 3729-3737.
9. Damy, T., Ratajczak, P., Robidel, E., Bendall, J.K., Oliviero, P., Boczkowski, J., Ebrahimian, T., Marotte, F., Samuel, J.L. and Heymes, C. (2003) Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J., 17, 1934-1936.
10. Burger, D.E., Lu, X., Lei, M., Xiang, F.L., Hammoud, L., Jiang, M., Wang, H., Jones, D.L., Sims, S.M. and Feng, Q. (2009) Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice. Circulation, 120, 1345-1354.
11. Damy, T., Ratajczak, P., Shah, A.M., Camors, E., Marty, I., Hasenfuss, G., Marotte, F., Samuel, J.L. and Heymes, C. (2004) Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet, 363, 1365-1367.
12. Bendall, J.K., Damy, T., Ratajczak, P., Loyer, X., Monceau, V., Marty, I., Milliez, P., Robidel, E., Marotte, F., Samuel, J.L. and Heymes, C. (2004) Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation, 110, 2368-2375.
13. Loyer, X., Gomez, A.M., Milliez, P., Fernandez-Velasco, M., Vangheluwe, P., Vinet, L., Charue, D., Vaudin, E., Zhang, W., Sainte-Marie, Y. et al. (2008) Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation, 117, 3187-3198.
14. Burkard, N., Williams, T., Czolbe, M., Blomer, N., Panther, F., Link, M., Fraccarollo, D., Widder, J.D., Hu, K., Han, H. et al. (2010) Conditional overexpression of neuronal nitric oxide synthase is cardioprotective in ischemia/reperfusion. Circulation, 122, 1588-1603.
15. Wehling-Henricks, M., Jordan, M.C., Roos, K.P., Deng, B. and Tidball, J.G. (2005) Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum. Mol. Genet., 14, 1921-1933.
16. Duan, D. (2006) Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy. Hum. Mol. Genet., 15, R253-R261.
17. Jessup, M., Greenberg, B., Mancini, D., Cappola, T., Pauly, D.F., Jaski, B., Yaroshinsky, A., Zsebo, K.M., Dittrich, H. and Hajjar, R.J. (2011) Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation, 124, 304-313.
18. Shin, J.H., Bostick, B., Yue, Y., Hajjar, R. and Duan, D. (2011) SERCA2a gene transfer improves electrocardiographic performance in agedmdxmice. J. Transl. Med., 9, 132.
19. Mingozzi, F. and High, K.A. (2011) Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet., 12, 341-355.
20. Lai, Y. and Duan, D. (2012) Progress in gene therapy of dystrophic heart disease. Gene Ther., 19, 678-685.
21. Zhong, L., Li, B., Mah, C.S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R.W., Zolotukhin, I., Warrington, K.H.J., Weigel-Van Aken, K.A. et al. (2008) Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc. Natl. Acad. Sci. USA, 105, 7827-7832.
22. Bostick, B., Yue, Y., Long, C., Marschalk, N., Fine, D.M., Chen, J. and Duan, D. (2009) Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol. Ther., 17, 253-261.
23. Bostick, B., Yue, Y. and Duan, D. (2010) Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy. Muscle Nerve, 42, 600-603.
24. Lai, Y., Yue, Y. and Duan, D. (2010) Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome . or 1/4 8.2 kb. Mol. Ther., 18, 75-79.
25. Snyder, S.H. and Ferris, C.D. (2000) Novel neurotransmitters and their neuropsychiatric relevance. Am. J. Psychiatry, 157, 1738-1751.
26. Brenman, J.E., Chao, D.S., Xia, H., Aldape, K. and Bredt, D.S. (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell, 82, 743-752.
27. Li, X., Eastman, E.M., Schwartz, R.J. and Draghia-Akli, R. (1999) Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences. Nat. Biotechnol., 17, 241-245.
28. Lai, Y., Zhao, J., Yue, Y. and Duan, D. (2013) alpha2 and alpha3 helices of dystrophin R16 and R17 frame a microdomain in the alpha1 helix of dystrophin R17 for neuronal NOS binding. Proc. Natl. Acad. Sci. USA, 110, 525-530.
29. Lai, Y., Thomas, G.D., Yue, Y., Yang, H.T., Li, D., Long, C., Judge, L., Bostick, B., Chamberlain, J.S., Terjung, R.L. and Duan, D. (2009) Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J. Clin. Invest., 119, 624-635.
30. Xu, K.Y., Huso, D.L., Dawson, T.M., Bredt, D.S. and Becker, L.C. (1999) Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc. Natl. Acad. Sci. USA, 96, 657-662.
31. Kanai, A.J., Pearce, L.L., Clemens, P.R., Birder, L.A., VanBibber, M.M., Choi, S.Y., de Groat, W.C. and Peterson, J. (2001) Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc. Natl. Acad. Sci. USA, 98, 14126-14131.
32. Bostick, B., Yue, Y., Long, C. and Duan, D. (2008) Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression. Circ. Res., 102, 121-130.
33. Bostick, B., Shin, J.H., Yue, Y. and Duan, D. (2011) AAV-microdystrophin therapy improves cardiac performance in aged femalemdxmice. Mol. Ther., 19, 1826-1832.
34. Bostick, B., Shin, J.H., Yue, Y., Wasala, N.B., Lai, Y. and Duan, D. (2012) AAVmicro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in .21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. J. Mol. Cell Cardiol., 53, 217-222.
35. Sandri, M., Minetti, C., Pedemonte, M. and Carraro, U. (1998) Apoptotic myonuclei in human Duchenne muscular dystrophy. Lab Invest., 78, 1005-1016.
36. Sandri, M., El Meslemani, A.H., Sandri, C., Schjerling, P., Vissing, K., Andersen, J.L., Rossini, K., Carraro, U. and Angelini, C. (2001) Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J. Neuropathol. Exp. Neurol., 60, 302-312.
37. Semenza, G.L. (2005) New insights into nNOS regulation of vascular homeostasis. J. Clin. Invest., 115, 2976-2978.
38. Huber-Abel, F.A., Gerber, M., Hoppeler, H. and Baum, O. (2012) Exercise-induced angiogenesis correlates with the up-regulated expression of neuronal nitric oxide synthase (nNOS) in human skeletal muscle. Eur. J. Appl. Physiol., 112, 155-162.
39. MacLennan, D.H. and Kranias, E.G. (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell. Biol., 4, 566-577.
40. Turner, P.R., Westwood, T., Regen, C.M. and Steinhardt, R.A. (1988) Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature, 335, 735-738.
41. Zhang, Y.H., Zhang, M.H., Sears, C.E., Emanuel, K., Redwood, C., El-Armouche, A., Kranias, E.G. and Casadei, B. (2008) Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice. Circ. Res., 102, 242-249.
42. Tsang, A., Hausenloy, D.J., Mocanu, M.M. and Yellon, D.M. (2004) Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ. Res., 95, 230-232.
43. Pons, S., Martin, V., Portal, L., Zini, R., Morin, D., Berdeaux, A. and Ghaleh, B. (2013) Regular treadmill exercise restores cardioprotective signaling pathways in obese mice independently from improvement in associated co-morbidities. J. Mol. Cell Cardiol., 54, 82-89.
44. Kawasome, H., Papst, P., Webb, S., Keller, G.M., Johnson, G.L., Gelfand, E.W. and Terada, N. (1998) Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. Proc. Natl. Acad. Sci. USA, 95, 5033-5038.
45. McMullen, J.R., Shioi, T., Zhang, L., Tarnavski, O., Sherwood, M.C., Dorfman, A.L., Longnus, S., Pende, M., Martin, K.A., Blenis, J., Thomas, G. and Izumo, S. (2004) Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy. Mol. Cell. Biol., 24, 6231-6240.
46. Fingar, D.C., Salama, S., Tsou, C., Harlow, E. and Blenis, J. (2002) Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev., 16, 1472-1487.
47. Pende, M., Um, S.H., Mieulet, V., Sticker, M., Goss, V.L., Mestan, J., Mueller, M., Fumagalli, S., Kozma, S.C. and Thomas, G. (2004) S6K1(-/-)/ S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell. Biol., 24, 3112-3124.
48. Shin, J.H., Pan, X., Hakim, C.H., Yang, H.T., Yue, Y., Zhang, K., Terjung, R.L. and Duan, D. (2013) Microdystrophin ameliorates muscular dystrophy in the Canine model of Duchenne muscular dystrophy. Mol. Ther., 21, 750-757.
49. Bostick, B., Yue, Y., Lai, Y., Long, C., Li, D. and Duan, D. (2008) Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice. Hum. Gene Ther., 19, 851-856.
50. Yue, Y., Ghosh, A., Long, C., Bostick, B., Smith, B.F., Kornegay, J.N. and Duan, D. (2008) A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol. Ther., 16, 1944-1952.
51. Wolf,C.M.,Moskowitz, I.P.,Arno,S.,Branco,D.M.,Semsarian,C.,Bernstein, S.A., Peterson,M.,Maida,M.,Morley,G.E., Fishman,G. et al. (2005)Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia. Proc. Natl. Acad. Sci. USA, 102, 18123-18128.
52. Papadopulos, F., Spinelli, M., Valente, S., Foroni, L., Orrico, C., Alviano, F. and Pasquinelli,G. (2007) Common tasks in microscopic and ultrastructural image analysis using ImageJ. Ultrastruct. Pathol., 31, 401-407.
53. Xu Z., Yue, Y., Lai, Y., Ye, C., Qiu, J., Pintel, D.J. and Duan, D. (2004) Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency. Hum. Gene Ther., 15, 896-905.